Business / Ghana

Ghana’s introduces new pharmaceutical manufacturing policy in response to $750 million annual drug import bill.

Ghana’s introduces new pharmaceutical manufacturing policy in response to $750 million annual drug import bill.

Ghana has rolled out a new pharmaceutical manufacturing policy in response to a $750 million annual drug import bill. The Ghana Pharmaceutical Manufacturing Policy aims to boost domestic drug production, draw in investment, and lessen the country’s reliance on imported medicines. It also sets out to establish Ghana as a pharmaceutical manufacturing and export hub for West Africa.

At the launch, Trade, Industry and Agribusiness Minister Elizabeth Ofosu-Adjare said the policy would open up fresh investment prospects and reinforce the local pharmaceutical sector.

She said the ministry’s job, following the president’s clear direction, was to turn that commitment into factories, products, exports, and jobs. According to her, the policy offers a framework for speeding up investment, encouraging local manufacturing, and making the industry more competitive.

She described the vision as straightforward: a Ghana that makes safe, quality, affordable medicines for its people and acts as West Africa’s pharmaceutical manufacturing hub.

German Ambassador to Ghana Frederik Landshöft also endorsed the policy, saying Germany was collaborating with Ghana to open up trade opportunities. He recalled how the COVID-19 pandemic exposed the vulnerability of countries when essential medicines and vaccines are made in just a few locations, which is why Germany strongly backs Ghana’s ambition to become a regional pharmaceutical manufacturing hub.

Speaking for the President of the Ghana Pharmaceutical Manufacturers Association (GPMA), the association’s Executive Secretary, Dr. Lucia Addae, welcomed the policy and expressed hope that it would support local manufacturers. She pointed to the country’s persistent dependence on imported medicines, noting that the value of pharmaceutical imports had risen sharply over the past decade.

She said people often hear that 70% of medicines are imported and 30% manufactured locally, and that this figure has stayed the same over the years. A decade ago, it stood at about $250 million; today it is a little over $750 million.

The policy is expected to create a framework for scaling up domestic pharmaceutical production, attracting investment, and boosting the competitiveness of Ghanaian manufacturers. How well it is implemented will be key to whether Ghana can raise local output, reduce its exposure to external supply disruptions, and build a stronger pharmaceutical export industry.

Share this story WhatsApp Facebook X
Originally published by MyJoyOnline
View on MyJoyOnline

Comments 0

No comments yet. Start the conversation.

Loading the next story…